Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 7Phase 1/2 4Phase 4 3Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Breast Neoplasms 13Lymphoma, Large B-Cell, Diffuse 4Leukemia, Lymphocytic, Chronic, B-Cell 4Neoplasm, Residual 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Burkitt Lymphoma 3Myelodysplastic Syndromes 2Lymphoma, Mantle-Cell 2Leukemia 2Hodgkin Disease 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Subcutaneous panniculitis-like T-cell lymphoma 1Rhabdomyosarcoma 1Recurrence 1Obesity 1Neoplasms, Plasma Cell 1Neoplasms 1Medulloblastoma 1Mediastinal Neoplasms 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Acute 1

Interventions

Vincristine 3Methotrexate 3Mercaptopurine 3Etoposide 3Daunorubicin 3Cytarabine 3Cyclophosphamide 3Asparaginase 3Vindesine 2Thioguanine 2Teniposide 2Stem Cell Transplantation 2Prednisolone 2Granulocyte Colony-Stimulating Factor 2Doxorubicin 2Dexamethasone 2pegaspargase 1fludarabine 1etoposide phosphate 1blinatumomab 1aldesleukin 1Rituximab 1Prednisone 1Pirinitramide 1Morphine 1Interleukin-2 1Idarubicin 1Histamine 1Cladribine 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Neoplasm, Residual × Cyclophosphamide × Clear all
NCT00198991 2022-08-18

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Goethe University

Phase 4 Completed
1,883 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00526175 2016-01-20

LAL-BR/2001: Study Treatment to Low Risk ALL

PETHEMA Foundation

Phase 4 Completed
150 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00199004 2010-08-23

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

Johann Wolfgang Goethe University Hospital

Phase 4 Completed
60 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡